Regulatory approvals are a significant factor affecting the timeline of nanotechnology products, especially in fields like nanomedicine. Regulatory bodies such as the FDA require extensive data on safety and efficacy, which can take years to compile and review. This regulatory scrutiny, while essential for public safety, can significantly extend the time from development to market.
